Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Novo-Nordisk
Company Monitoring Page for Novo-Nordisk
latest headlines for company on cafepharma
Early data hint at benefit for Amgen’s obesity drug
BioPharma Dive
Wed, 11/9/22 - 10:32 am
Tags:
Amgen
,
obesity
,
Eli Lilly
,
Novo Nordisk
,
AMG 133
Novo Nordisk’s Ozempic Shortage Spurs Demand for Eli Lilly’s Diabetes Injection Mounjaro
Xtalks
Thu, 11/3/22 - 07:25 pm
Tags:
Eli Lilly
,
Mounjaro
,
Novo Nordisk
,
Ozempic
,
type 2 diabetes
Just announced: upcoming late-stage clinical trials in weight loss and diabetes
Clinical Trials Arena
Sun, 10/23/22 - 07:09 pm
Tags:
clinical trials
,
Eli Lilly
,
Novo Nordisk
,
weight loss
,
diabetes
,
Ozempic
,
Wegovey
,
Mounjaro
After selling startups to Novo and Pfizer, Andera raises record €456M for latest life sciences fund
Fierce Biotech
Mon, 10/10/22 - 10:30 am
Tags:
Andera Partners
,
funding
,
life sciences
,
startups
,
Pfizer
,
Novo Nordisk
,
Europe
,
venture capital
Lilly's tirzepatide slides into FDA fast lane for obesity, turning up heat on Novo Nordisk's Wegovy
Fierce Pharma
Thu, 10/6/22 - 10:59 am
Tags:
Eli Lilly
,
Novo Nordisk
,
obesity
,
FDA
,
fast track
,
tirzepatide
Novo Nordisk ready to submit once-weekly insulin to FDA after scoring final phase 3 win
Fierce Biotech
Wed, 10/5/22 - 07:11 pm
Tags:
Novo Nordisk
,
FDA
,
diabetes
,
insulin
,
basal insulin
,
Icodec
Decades-old law keeping older adults from trying new weight loss therapies - and companies are paying millions to try to get it changed
Marketwatch
Wed, 10/5/22 - 10:46 am
Tags:
Medicare
,
Wegovy
,
Novo Nordisk
No big bang for biopharma buyouts
EP Vantage
Wed, 10/5/22 - 10:29 am
Tags:
M&A
,
Pfizer
,
Global Blood Therapeutics
,
Amgen
,
ChemoCentryx
,
Novo Nordisk
,
Forma
,
Alcon
,
Aerie Pharmaceuticals
,
Gilead Sciences
,
MiroBio
Ventus sells its lead drug candidate to Novo Nordisk
BioPharma Dive
Thu, 09/29/22 - 09:48 am
Tags:
Ventus Therapeutics
,
Novo Nordisk
,
inflammatory diseases
,
VENT-01
Novo Nordisk, Gilead, BMS and AstraZeneca will feel the most pain from Biden's pricing bill: analysts
Fierce Pharma
Mon, 09/26/22 - 11:25 pm
Tags:
Inflation Reduction Act
,
Joe Biden
,
Novo Nordisk
,
Gilead Sciences
,
Bristol Myers Squibb
,
AstraZeneca
,
drug pricing
Novo's Once-Weekly Insulin Treatment Part of a Transforming T2D Space
BioSpace
Thu, 09/22/22 - 10:14 am
Tags:
Novo Nordisk
,
clinical trials
,
type 2 diabetes
,
diabetes
,
insulin icodec
Novo Nordisk and Microsoft collaborate to accelerate drug discovery and development using big data and artificial intelligence
Yahoo Finance
Mon, 09/12/22 - 10:55 am
Tags:
Novo Nordisk
,
Microsoft
,
drug discovery
,
artificial intelligence
,
Big Data
Zealand Pharma, Novo Nordisk Ink Licensing Pact For Diabetes Drug
Yahoo/Benzinga
Wed, 09/7/22 - 10:15 am
Tags:
Zealand Pharma
,
Novo Nordisk
,
Zegalogue
,
diabetes
,
hypoglycemia
Targeting Novo Nordisk in China's obesity market with a unique proposition, LeaderMed eyes US IPO
Fierce Biotech
Fri, 09/2/22 - 12:32 pm
Tags:
Novo Nordisk
,
obesity
,
China
,
IPOs
Novo Nordisk to acquire Forma Therapeutics in $1.1. bln deal
Yahoo/Reuters
Thu, 09/1/22 - 10:49 am
Tags:
Novo Nordisk
,
Forma Therapeutics
,
M&A
,
blood disorders
ESC 2022 – Novo’s cardiovascular charge continues
EP Vantage
Thu, 09/1/22 - 10:13 am
Tags:
ESC 2022
,
Novo Nordisk
,
ziltivekimab
,
PRX004
,
HS-001
A pharmaceutical jack of all trades? Novo CEO touts semaglutide's potential in NASH, Alzheimer's and its hot start in obesity
Fierce Pharma
Mon, 08/29/22 - 10:40 am
Tags:
Novo Nordisk
,
semaglutide
,
NASH
,
Alzheimer's disease
,
Saxenda
,
obesity
Novo Nordisk successfully completes phase 2 trial with CagriSema in people with type 2 diabetes
Yahoo Finance
Mon, 08/22/22 - 10:00 am
Tags:
Novo Nordisk
,
clinical trials
,
CagriSema
,
semaglutide
,
diabetes
,
type 2 diabetes
Amid Wegovy's supply woes, Novo Nordisk sees surging demand for its original obesity drug Saxenda
Fierce Pharma
Thu, 08/4/22 - 11:05 am
Tags:
Novo Nordisk
,
obesity
,
drug manufacturing
,
Wegovy
Novo Nordisk's once-weekly insulin marches on after hitting goals in pair of phase 3 trials
Fierce Biotech
Fri, 07/29/22 - 09:54 am
Tags:
Novo Nordisk
,
insulin
,
diabetes
,
insulin icodec
,
clinical trials
Pages
« first
‹ previous
…
19
20
21
22
23
24
25
26
27
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.